Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Novavax

Looking At Novavax's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Australia has approved the Novavax COVID-19 vaccine for adults. Here’s why it’s a game changer

The Novavax COVID-19 vaccine has been approved in Australia, and it's set to play a big part in future vaccine rollouts around the world.

The New Daily

Novavax COVID vaccine gets final ATAGI approval, rollout to start in February

The vaccine now has the final approval from ATAGI and is set to be rolled out across the country toward the end of February.

ABC News

From analysis to the latest developments in health,
read the most diverse news in one place.

Australia records 58 Covid deaths; Hunt says ‘hoarding’ affecting rapid test shortage – as it happened

This blog is now closed

The Guardian - AU

Novavax Covid vaccine: what is it and will it make a difference?

Australia’s government is hoping the protein-based vaccine – approved by the TGA – will sway the hesitant to get the jab

The Guardian - AU

What The Future Might Hold For Novavax Stock

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Thursday after Australia’s national drug regulator granted approval for the company's COVID-19 vaccine. The stock is trading below what traders call a pennant pattern and is showing uncertainty in where it could head next.

Benzinga

The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Novavax Scores Approval From Australian Regulator For COVID-19 Vaccine

Novavax Inc (NASDAQ: NVAX) said Wednesday that Australia’s national drugs regulator has granted approval for its COVID-19 vaccine.

Benzinga

The Novavax COVID-19 vaccine has been approved for use in Australia — but when will it be here?

You might be wondering, why do we need another vaccine at all when most of us are fully vaccinated and some have received a booster? Here's what you need to know.

ABC News

Novavax becomes Australia's 5th approved COVID-19 vaccine

Novavax's COVID-19 vaccine has become the fifth coronavirus vaccine approved for use in Australia

The Independent UK

TGA approves Novavax COVID vaccine, anti-viral pills to treat disease in vulnerable patients

The national drug regulator has approved the Novavax vaccine, as well as two oral treatments for vulnerable patients with COVID-19.

ABC News

This Is What Whales Are Betting On Novavax

A whale with a lot of money to spend has taken a noticeably bullish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 34 strange trades.

Benzinga

1 … 7 8 9 10

People

Annastacia Palaszczuk

Terence Darrell Kelly

28 stories

Terence Kelly

19 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Bureau of Meteorology

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.